Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): look to the future
Tommaso Cai,Jakhongir Alidjanov,Ivan Palagin,José Medina-Polo,J. Curtis Nickel,Florian M. E. Wagenlehner
DOI: https://doi.org/10.1038/s41391-023-00645-7
2023-01-12
Prostate Cancer and Prostatic Diseases
Abstract:Why are we still talking about the management of chronic prostatitis 50 years after the first historical paper describing the culture technique for prostatitis-like symptoms [1] and 40 years after the first traditional classification [2]? In 2000, Nickel et al. initiated a new era in prostatitis research and management [3] by presenting a new classification system followed by general consensus on the direction of prostatitis research [3]. However, still today prostatitis, particularly the chronic cases, represents a perplexing challenge in everyday clinical practice. In this perspective article, we discuss the relevant missing needs in the clinical management and research in chronic prostatitis, specifically chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Main clinical outcomes in prostatitis: the paradigmatic shift from symptoms to quality of life. What do the patients want from the therapy? Generally, in all areas of medicine, patients request a reduction of symptoms rather than an improvement in laboratory test results. Prostatitis represents an enigmatic clinical entity that impacts many aspects of a patient's life. In 2009, Nickel et al. described the 'Snow Flake Hypothesis', hypothesising that chronic prostatitis patients are not a homogenous group suffering from a single disease entity but suffer from a complex multi-faceted symptomatic syndrome [4]. From this theory arose the first holistic approach to CP/CPPS, with the introduction in everyday clinical practice of UPOINT (urinary, psychosocial, organ-specific, infection, neurologic/systemic, and tenderness domains) clinical phenotyping classification [4]. For the first time, the target of the treatment was not the 'prostate' alone but a systemic approach targeting the entire clinical picture associated with each unique patient. This concept led to a patient-centred or personalised medicine management strategy [5]. A patient-centred approach has proven useful to patient's understanding of what is causing their symptoms, improving adherence to treatment, potentially reducing complications, costs and ultimately offering the best chance of ameliorating symptoms and improving patients' quality of life [6]. A holistic approach incorporating an individual patient phenotype-directed management strategy for patients affected by prostatitis is needed in order to make a real beneficial impact with respect to a patient's pain and urinary symptoms, life activities and quality of life.
oncology,urology & nephrology